Name | Licogliflozin |
---|
Description | Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor. |
---|---|
Related Catalog | |
Target |
SGLT1, SGLT2[1] |
In Vitro | Licogliflozin (LIK066) is a non-anti-fibrotic treatment agent for non-alcoholic steatohepatitis (NASH). |
References |
Molecular Formula | C23H28O7 |
---|---|
Molecular Weight | 416.46 |
Storage condition | 2-8℃ |